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EDITORIAL COMMENT
Age: A Nonmodifiable
Risk Factor?*
Mathew S. Maurer, MD
New York, New York
Chronologic age has been identified in almost all cardiovas-
cular investigations as a potent, independent risk for in-
creased morbidity and mortality. As clinical cardiologists,
we are constantly faced with diagnostic or treatment deci-
sions regarding what is “appropriate” for an older individual.
In the absence of sound evidence, these decisions can be
strongly influenced by the stereotypic and often negative
perception of older adults (1).
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The percentage of older patients constituting a cardiolo-
gist’s practice has increased from under 40% in the late
1970s to almost 60% (2). Despite progressive declines in
age-adjusted mortality rates from coronary heart disease and
hypertensive cardiovascular disease (3), the incidence and
prevalence of heart failure both in the setting of an impaired
and preserved ejection fraction, chronic ischemic heart
disease, and atrial fibrillation are increasing, and it has been
projected that these rates will continue well into the 21st
century (4,5). Thus, we have many new yet-older consumers
in need of our cardiovascular expertise.
Perceptions of elders as debilitated, disabled, and depen-
dent are yielding to a recognition that a growing population
of older adults are “aging successfully” with independent,
functional lives (6). Until recently, a widely held view in
cardiology was that the risk of our interventions for elders
was high and the perceived benefits low (7). However, over
the past three decades, cardiologists have gained a wealth of
experience and judgment in the management of older
patients as evidenced by the development and application of
coronary artery bypass graft surgery (CABG). In the Cor-
onary Artery Surgery Study (CASS) registry of 8,913
patients who underwent CABG in the period from 1975 to
1979, 12.2% were 65 years of age and older (8). Two
decades later, 56% of the nearly 600,000 CABG operations
in the U.S. were being performed in patients 65 years of age
and older. Clearly, the cardiovascular community has em-
braced the performance of CABG for the older individual.
However, numerous publications documented that among
octogenarians there was a high perioperative mortality
(9,10). In an effort to understand these outcomes, cardio-
vascular researchers identified predictors of perioperative
mortality in elders, including but not limited to urgency of
the surgery, severity of cardiovascular disease, renal insuffi-
ciency, lower body mass index, and comorbid conditions
(11–14). We have recognized the increased risks, identified
some predictors, and now can provide our older patients
with meaningful probabilities for short-term survival. How-
ever, is it sufficient to recommend a procedure merely
because it could be performed within acceptable limits of
mortality?
Over the last few years, the quality of life outcomes in
older patients undergoing CABG surgery have become a
major issue. Quality of life outcomes cover the sustained
impact of cardiovascular limitations on living, including
function and symptom distress. These are reasonable and
appropriate outcome measures because they are major con-
cerns of our older patient population. In recent years there
have been several investigations documenting that after
CABG there is a general increase in quality of life, sense of
well being, and satisfaction with the decision to undergo the
operation (15–17); however, these results have come from
small single-center studies. In this issue of the Journal,
Conaway et al. (18) provide us further answers and insights
regarding the role of surgical revascularization in the elderly
patient with coronary artery disease. Using a prospective
design, a consecutive series of 690 patients undergoing
CABG had serial assessments of the impact of the proce-
dure on measures of functional status, symptom burden, and
quality of life. Older patients were shown to have absolute
improvements in physical function, angina frequency, and
quality of life, and there were no statistically significant
differences in these respects between older and younger
subjects. In fact, there were trends toward greater reduction
in angina frequency and greater increase in overall quality of
life one year after surgery in the elderly. These findings,
taken together with previous studies, indicate that in older
subjects there is an increased baseline risk (19), leading to
the inference that elderly patients may benefit more from
our interventions than younger counterparts.
We have begun to seek answers on how to minimize the
risks of adverse perioperative outcomes observed during our
experiences applying surgical revascularization to the elderly
population. For example, the role of off-pump procedures in
reducing the risk of cognitive decline observed after cardio-
pulmonary bypass, especially in the elderly patients, has
been a focus of active investigation (20). What should be
our reaction to the observation delineated by Conaway et al.
(18) that functional recovery is delayed in our older patients?
Is it an inevitable outcome in older individuals after such
aggressive interventions? Or should we do what we have
done for decades: identify the risk factors for delayed
functional recovery; develop targeted interventions involv-
ing interdisciplinary approaches; and test in rigorously
designed, large, multicenter trials whether we can change
what we currently perceive to be non-modifiable? Such
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studies can provide meaningful data that permit generaliz-
able information to the growing population of elders un-
dergoing CABG and provide sufficient power to identify
predictors of quality of life outcomes in relevant subgroups
of elders undergoing revascularization procedures.
In the care of older patients, cardiology has been at the
forefront of creating a model for subspecialty involvement.
Initially, faced with the growing population of older indi-
viduals in need of our services, cardiologists and cardiac
surgeons developed experience in caring for these individu-
als. These experiences contradicted classic paradigms, sug-
gesting that our services could be provided with reasonable
risks and with potentially much gain. Amazing advance-
ments in the delivery of care has permitted us to apply
valuable, life-preserving techniques to the elderly. Future
investigations should continue to challenge our bias against
treating the elderly, demanding rigorous investigation into
the factors that impair quality and quantity of life for the
elderly patient with cardiovascular disease. We should not
assume that age is a non-modifiable risk for worse out-
comes. Rather, we need to understand the biological,
psychological, and social factors that result in poor outcomes
for our older clientele and develop systems of care capable of
addressing these issues. After all, where we once would have
treaded cautiously when treating a 65-year-old patient, we
now routinely perform cardiac surgery on 80-year-old pa-
tients. Our perception of what constitutes “old” is continu-
ally changing. This has been exemplified by the progress we
have achieved in providing cardiovascular care to a growing
and constantly older set of individuals (21).
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